Switch to:
More From Other Websites
The Medicines Company to Webcast Infectious Disease Care Investor & Analyst Day on September 24 Sep 23 2014
The Medicines Company to Review ORBACTIVTM Call scheduled for 7:30 am ET today Sep 16 2014
The Medicines Company to Review ORBACTIVTM (oritavancin) Launch Readiness on Tuesday, September 16,... Sep 12 2014
The Medicines Company to Present New Data from its Infectious Disease Portfolio at the 54th... Aug 27 2014
MEDICINES CO /DE Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 11 2014
MEDICINES CO /DE Financials Aug 09 2014
The Medicines Company's Orbactiv Approved on Solid SOLO Data Aug 07 2014
[$$] The Medicines Co. Offers Investors 25% Upside Aug 07 2014
Is Durata's Antibiotic Overpriced? A Twitter Conversation Aug 07 2014
The Medicines Company and Alnylam Pharmaceuticals to Host RNAi Roundtable Webcast “ALN-PCSsc for... Aug 07 2014
Medicines Co's ORBACTIVT FDA Approval Call scheduled for 8:00 am ET today Aug 07 2014
FDA Approves The Medicines Company's ORBACTIV™ (oritavancin) for Use in Acute Bacterial Skin and... Aug 06 2014
The R&D elite: America's most innovative companies Aug 06 2014
MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report Aug 04 2014
The Medicines Company to Host Infectious Disease Care Investor and Analyst Meeting on September 24,... Aug 04 2014
The Medicines Co.'s (MDCO) Q2 Earnings Decline Y/Y Jul 24 2014
Medicines (MDCO) is Oversold: Can It Recover? Jul 24 2014
Medicines Co Earnings Call scheduled for 8:30 am ET today Jul 23 2014
MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 23 2014
Q2 2014 The Medicines Company Earnings Release - Before Market Open Jul 23 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK